- Home
- NRIX vs EFSC Comparison
NRIX vs EFSC Comparison
Compare NRIX & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | EFSC |
|---|---|---|
| Founded | 2009 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NRIX | EFSC |
|---|---|---|
| Price | $25.37 | $61.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $34.50 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 1.9M | 177.5K |
| Earning Date | 10-12-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ 9.94 |
| EPS | ★ 3.26 | 2.39 |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | $786.93 | $4.01 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | ★ $7.82 | $25.48 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $11.19 | $51.18 |
| 52 Week High | $28.23 | $68.73 |
Technical Indicators
Market Signals| Indicator | NRIX | EFSC |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 55.58 |
| Support Level | $24.61 | $61.16 |
| Resistance Level | $28.23 | $61.65 |
| Average True Range (ATR) | 1.21 | 1.17 |
| MACD | 0.39 | 0.39 |
| Stochastic Oscillator | 81.41 | 81.04 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Its Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.